Brief: Ambalal Sarabhai Ups Production Of Amphotericin B In Wake Of Mucormycosis Outbreak
11/05/2021 15:00
May 11 (Reuters) - Ambalal Sarabhai Enterprises Ltd
AMBL.BO :
* RAMPED UP PRODUCTION OF AMPHOTERICIN B IN WAKE OF
MUCORMYCOSIS
OUTBREAK
Source text for Eikon: ID:nBSE7hWL2x
Further company coverage: AMBL.BO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Ambalal Sarabhai Enterprises
See all newsBrief: Ambalal Sarabhai Enterprises Says Telerad Division Of Unit Signs Agreement With Bolin Technology
Brief: Ambalal Sarabhai Enterprises Says CFO Navinchandra Patel Resigns
Brief: Ambalal Sarabhai Enterprises Names Mohal K. Sarabhai As MD
Brief: Ambalal Sarabhai Enterprises Says Unit Asence Pharma Commences New Oncology And Synthetic API Plant At Ranoli, Vadodara
Brief: India's Ambalal Sarabhai Enterprises Dec-Qtr Consol Net Profit Falls